Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

PierPaolo Peruzzi, M.D., Ph.D.

Concepts (140)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glioblastoma13202333461.780 Why?
Glioma5202333180.920 Why?
MicroRNAs6201937150.920 Why?
Brain Neoplasms11202386570.890 Why?
Poliovirus120181080.650 Why?
Comovirus1201550.570 Why?
Genetic Engineering220199460.530 Why?
Neurosurgery120216290.520 Why?
Vestibular Nerve120141010.500 Why?
Oncolytic Virotherapy420234900.480 Why?
Transgenes2201910160.410 Why?
Gene Expression Regulation, Neoplastic4201984520.400 Why?
Neuroma, Acoustic120144330.390 Why?
Neoplasms, Experimental1201512980.370 Why?
Craniotomy220117300.350 Why?
Supratentorial Neoplasms120101620.340 Why?
Oncolytic Viruses220233180.340 Why?
NF-E2-Related Factor 2120113590.340 Why?
Peripheral Nervous System Neoplasms120091250.330 Why?
Electromagnetic Fields120102990.330 Why?
Cancer Vaccines1201510090.330 Why?
Brachial Plexus Neuropathies120091220.320 Why?
Conscious Sedation120105170.270 Why?
Blood-Brain Barrier120119860.270 Why?
Fetal Diseases120108840.260 Why?
Neoplastic Stem Cells1201313780.260 Why?
Nanoparticles1201519010.240 Why?
Monitoring, Intraoperative120119570.240 Why?
Wakefulness1201112310.240 Why?
Central Nervous System1201013010.230 Why?
Central Nervous System Neoplasms120118570.230 Why?
Anesthesia, General1201011450.220 Why?
Lymphoma, B-Cell120099290.220 Why?
Ultrasonography, Prenatal1201016620.220 Why?
Nervous System Diseases2201016200.210 Why?
Angiogenesis Inhibitors1201120310.200 Why?
Antineoplastic Agents, Alkylating220196190.200 Why?
Cell Movement2201352870.190 Why?
Herpesvirus 1, Human120237490.160 Why?
Gamma Rays120193260.160 Why?
Magnetic Resonance Imaging42011347760.140 Why?
Genetic Vectors3201934470.140 Why?
Histone Demethylases120193160.140 Why?
Drug Delivery Systems2202322300.130 Why?
Humans2620237251870.120 Why?
Cloning, Molecular1201943880.120 Why?
Pharmaceutical Preparations1202110480.120 Why?
Neuroglia120199220.120 Why?
Melanoma1201153580.110 Why?
Postoperative Complications22011150190.110 Why?
Mice, Nude1201937130.110 Why?
Signal Transduction22014234480.110 Why?
Cluster Analysis1201927610.100 Why?
Tumor Microenvironment3202333350.100 Why?
Xenograft Model Antitumor Assays1201935740.100 Why?
Neurosurgical Procedures1202119950.090 Why?
Animals1020211687140.090 Why?
Survival Analysis22023102510.090 Why?
Medical Oncology1202121620.090 Why?
Neurons1200993440.090 Why?
False Negative Reactions120105880.090 Why?
Anesthesia, Inhalation120102210.090 Why?
Exosomes120133950.090 Why?
Chromosomes, Artificial, Bacterial120091280.090 Why?
Proto-Oncogene Proteins c-bcl-6120091920.090 Why?
Clinical Trials, Phase I as Topic120103170.080 Why?
Clinical Trials as Topic3202278400.080 Why?
False Positive Reactions120109910.080 Why?
Etoposide120096370.080 Why?
Dacarbazine120105670.080 Why?
Vincristine1200910500.080 Why?
Clinical Trials, Phase III as Topic120107950.070 Why?
Antibodies, Monoclonal, Murine-Derived120096980.070 Why?
Multicenter Studies as Topic1201015330.070 Why?
Antimetabolites, Antineoplastic120096390.070 Why?
Epigenesis, Genetic1201935960.070 Why?
Prednisone1200915490.060 Why?
Cell Line, Tumor22019166300.060 Why?
Costs and Cost Analysis1201016670.060 Why?
Mice42019803000.060 Why?
Hydrocephalus120107360.060 Why?
Phenotype12021162720.060 Why?
Cyclophosphamide1200922050.060 Why?
Postoperative Care1201014880.060 Why?
Gene Expression Profiling1201993790.060 Why?
alpha-Synuclein120096860.060 Why?
Cell Proliferation12019104770.060 Why?
Doxorubicin1200922260.060 Why?
Methotrexate1200917110.050 Why?
Radiosurgery1201112680.050 Why?
Gestational Age1201034430.050 Why?
Female720193754490.050 Why?
Neoplasm Proteins1201337110.050 Why?
Neoplasm Metastasis1201148960.050 Why?
Neoplasm Recurrence, Local1201889180.050 Why?
Cerebral Hemorrhage1201125760.050 Why?
Neoplasms22021209410.050 Why?
Interleukin-12120225930.040 Why?
tau Proteins1200917500.040 Why?
Reproducibility of Results22023196240.040 Why?
Pathology, Molecular120223360.040 Why?
Follow-Up Studies22010387480.040 Why?
Prognosis32019287370.040 Why?
Combined Modality Therapy1201086170.040 Why?
Treatment Outcome32023617610.040 Why?
Critical Care1201025800.040 Why?
Workflow120218280.040 Why?
Length of Stay1201062340.040 Why?
Retrospective Studies32022742060.030 Why?
Antineoplastic Combined Chemotherapy Protocols22022113240.030 Why?
Sensitivity and Specificity12010147210.030 Why?
Immunohistochemistry12009114840.030 Why?
Adult420222116150.030 Why?
Prostheses and Implants1202113620.030 Why?
Microglia1202212130.030 Why?
Transcription Factors12013120800.030 Why?
Cells, Cultured12009194850.030 Why?
Male420113470960.030 Why?
Rats12009244140.030 Why?
Antibodies, Monoclonal1200992450.030 Why?
Spheroids, Cellular120133410.030 Why?
High-Throughput Nucleotide Sequencing1202236430.020 Why?
Biological Transport1201321170.020 Why?
Pregnancy12010281450.020 Why?
Cohort Studies12010399180.020 Why?
Aged220101614860.020 Why?
Immunotherapy1202242570.020 Why?
Antineoplastic Agents12009135760.020 Why?
T-Lymphocytes12023100070.020 Why?
Tumor Cells, Cultured1201363710.020 Why?
Gene Regulatory Networks1201417190.020 Why?
Neoplasm Invasiveness1201336280.020 Why?
Simplexvirus120098030.020 Why?
Neovascularization, Pathologic1201326500.010 Why?
Clinical Protocols1200914500.010 Why?
Adolescent12011844010.010 Why?
Gene Expression1201378190.010 Why?
Mutation12022296720.010 Why?
Middle Aged120102122920.010 Why?
Disease Models, Animal12013180330.010 Why?
Peruzzi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (140)
Explore
_
Co-Authors (59)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.